Mark Sheptoff Financial Planning’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5K | Hold |
100
| – | – | 0.03% | 182 |
|
|
2025
Q1 | $63.4K | Hold |
100
| – | – | 0.04% | 153 |
|
|
2024
Q4 | $71.2K | Hold |
100
| – | – | 0.04% | 148 |
|
|
2024
Q3 | $105K | Sell |
100
-35
| -26% | -$36.8K | 0.06% | 119 |
|
|
2024
Q2 | $142K | Buy |
135
+35
| +35% | +$36.8K | 0.08% | 110 |
|
|
2024
Q1 | $96.2K | Hold |
100
| – | – | 0.05% | 133 |
|
|
2023
Q4 | $87.8K | Hold |
100
| – | – | 0.05% | 126 |
|
|
2023
Q3 | $82.3K | Hold |
100
| – | – | 0.05% | 120 |
|
|
2023
Q2 | $71.9K | Hold |
100
| – | – | 0.04% | 135 |
|
|
2023
Q1 | $82.2K | Hold |
100
| – | – | 0.05% | 126 |
|
|
2022
Q4 | $72.1K | Sell |
100
-50
| -33% | -$36.1K | 0.04% | 132 |
|
|
2022
Q3 | $103K | Hold |
150
| – | – | 0.06% | 105 |
|
|
2022
Q2 | $89K | Hold |
150
| – | – | 0.05% | 123 |
|
|
2022
Q1 | $105K | Hold |
150
| – | – | 0.05% | 133 |
|
|
2021
Q4 | $95K | Hold |
150
| – | – | 0.05% | 140 |
|
|
2021
Q3 | $91K | Hold |
150
| – | – | 0.05% | 145 |
|
|
2021
Q2 | $84K | Hold |
150
| – | – | 0.05% | 147 |
|
|
2021
Q1 | $71K | Hold |
150
| – | – | 0.04% | 139 |
|
|
2020
Q4 | $72K | Hold |
150
| – | – | 0.04% | 142 |
|
|
2020
Q3 | $84K | Hold |
150
| – | – | 0.05% | 125 |
|
|
2020
Q2 | $94K | Hold |
150
| – | – | 0.06% | 118 |
|
|
2020
Q1 | $73K | Buy |
+150
| New | +$73K | 0.06% | 115 |
|
|
2015
Q4 | – | Sell |
-2
| Closed | -$1K | – | 420 |
|
|
2015
Q3 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 383 |
|